CTLT  valuation analysis

Basics
Name: Catalent, Inc
Description: Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2021
Market cap: $18.68B (353rd)
Sales(TTM): $3.76B (542nd)
Earnings(TTM): $556.80M (365th)

Value
FFER: 2.12*
Actual price: $109.70
* Earnings were reported Aug 30, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Catalent, Inc
"Drug Manufacturers-Specialty & Generic" industry